Key result
Circulating tricarboxylic acid cycle intermediate levels, specifically plasma α-ketoglutarate and fumarate, were significantly associated with right ventricular-pulmonary artery uncoupling.
Why the study?
RV maladaptation to elevated pulmonary afterload determines outcomes in PA hypertension, but the pathobiological mechanisms underlying RV decompensation remain poorly understood.
Observational (n=1,114)
Yes
Dysregulated TCA cycle metabolism, marked by elevated circulating intermediates like α-ketoglutarate and fumarate, is associated with right ventricular maladaptation in pulmonary artery hypertension.
Answers are grounded in this paper and cite their sources.
Metabolomic signatures of RV maladaptation in PAH are hypothesis-generating; leaves open any role in risk stratification or therapy selection.
BACKGROUND: Right ventricular (RV) maladaptation to elevated pulmonary afterload is the primary determinant of outcomes in pulmonary artery (PA) hypertension; however, the pathobiological mechanisms underlying RV decompensation remain poorly understood. METHODS: We performed global untargeted metabolomics on plasma from 55 patients who underwent gold-standard RV-PA coupling measurements using multibeat pressure volume loop assessment in a single-center cohort and from 1027 patients with coupling surrogate measurements in a larger multicenter cohort, the PVDOMICS (Pulmonary Vascular Disease Phenomics) study. Age and sex-adjusted linear regression was performed to identify associations between metabolites and coupling metrics. Additionally, we performed a metabolic flux analysis using gene expression data from RV tissue in an independent cohort of 32 patients. Partial least squares-discriminant analysis was used to identify metabolites and reactions characteristic of the decompensated RV. RESULTS: RV-PA coupling was negatively associated with tricarboxylic acid (TCA) cycle intermediate levels. Specifically, plasma α-ketoglutarate and fumarate were significantly associated with all coupling metrics in both cohorts. Metabolic flux analysis indicated that decompensated RVs exhibited aberrant TCA cycle activity, including reduced acetyl coenzyme A entry and increased lactate elimination, suggesting a shift from the TCA cycle toward glycolysis at the RV tissue level. CONCLUSIONS: We identify an association between circulating TCA cycle intermediate levels and RV-PA uncoupling in 2 independent cohorts, and dysregulated TCA cycle metabolism in decompensated PA hypertension RVs, suggesting that aberrant TCA cycle metabolism could represent a hallmark of RV maladaptation in PA hypertension. Further study of this pathway is warranted to develop novel biomarkers of RV function or RV-targeted therapies.
No takes yet. Share an insight, caveat, or question.
Rosen et al. (2025) conducted an observational in Pulmonary artery hypertension (n=1,114). Tricarboxylic acid (TCA) cycle intermediate levels was evaluated on Right ventricular-pulmonary artery (RV-PA) coupling. Circulating tricarboxylic acid cycle intermediate levels, specifically plasma α-ketoglutarate and fumarate, were significantly associated with right ventricular-pulmonary artery uncoupling.
Synapse has enriched 10 related papers. Consider them for comparative context: